MEI Pharma | 4: Statement of changes in beneficial ownership of securities-Director Wood Steven D
MEI Pharma | 4: Statement of changes in beneficial ownership of securities-Director Flynn James P
MEI Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-TANG CAPITAL PARTNERS, LP(4.9%),Tang Capital Management, LLC(4.9%), etc.
MEI Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(5.85%)
MEI Pharma | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Flynn James P
MEI Pharma | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Wood Steven D
MEI Pharma | 4: Statement of changes in beneficial ownership of securities-Director Wood Steven D
MEI Pharma | 4: Statement of changes in beneficial ownership of securities-Director Flynn James P
MEI Pharma | 3: Initial statement of beneficial ownership of securities-Director Wood Steven D
MEI Pharma | 3: Initial statement of beneficial ownership of securities-Director Datoo Taheer
MEI Pharma | 3: Initial statement of beneficial ownership of securities-Director Flynn James P
MEI Pharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Anson Funds Management LP(16.4%),Anson Management GP LLC(16.4%), etc.
MEI Pharma | 4: Statement of changes in beneficial ownership of securities-10% Owner Funicular Funds, LP
MEI Pharma | 4: Statement of changes in beneficial ownership of securities-10% Owner Anson Funds Management LP
MEI Pharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Anson Funds Management LP(16.4%),Anson Management GP LLC(16.4%), etc.
MEI Pharma | 4: Statement of changes in beneficial ownership of securities-10% Owner Funicular Funds, LP
MEI Pharma | 4: Statement of changes in beneficial ownership of securities-10% Owner Anson Funds Management LP
MEI Pharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Anson Funds Management LP(13.7%),Anson Management GP LLC(13.7%), etc.
MEI Pharma | 4: Statement of changes in beneficial ownership of securities-Director Baltic Charles V. III
MEI Pharma | 4: Statement of changes in beneficial ownership of securities-Director DRISCOLL FREDERICK W
No Data